Well what can one say about Sareum? The sp has increased many times since they released news on Sareum’s ; Aurora+FLT3 Kinase programme.
Some are hailing it as a possible cancer wonder drug others are just completely shell-shocked that Sareum managed to keep the results under wraps! No leaks or pointers other than Director options in December 2010! So what’s it all about well read below:
“The recent pre-clinical in-vivo study for Sareum’s Aurora+FLT3 Kinase programme, targeting the most common form of adult leukaemia, showed that the leukaemia had regressed to such an extent that no detectable cancer could be found in any of the cases treated – ten in total.
By comparison, leukaemia increased five to fifteen fold in the study examples treated without Sareum’s compound”
Phew! Sounds like Sareum have hit the Jackpot!
Well not according to Sareum who are trying to dampen down speculation of Licensee agreements “The Company can confirm that it is not currently in advanced stages of discussion with a potential licensing partner” Pull the other one Sareum!
Of course that statement is strictly true they are not in discussion with “A LICENSE PARTNER because they ARE in discussion WITH SEVERAL LICENSE PARTNERS! Semantics!
So just what stage are Sareum at? It is a racing certainty that Sareum are indeed in talks regarding license agreements with several partners!
“The Company can confirm that the results of the study have, in the ordinary
course of business, been sent to potential licencing partners and the Company
will be engaging with these partners to determine their interest in the data.”
Sareum have just become one of the Hottest Takeover targets in the Pharm’s sector! And make no mistake here at the very least when the mist clears there could be several partners signed up for Aurora+FLT3! It’s all a matter of opinion of course but these miracle drug discoveries if firmed up can explode.
How high could this go? Now there’s a question? No one at this point can answer. It all depends on partner agreements and possible merger value to prospective buyers but there’s been many a small Pharm swallowed by multi-nationals at mouth-watering prices. I suppose the answer to the question is another question; What’s the value of a cure for Leukaemia/Cancer?
Hold your stock it COULD very well be worth 100 times its current value! Over time! (0.8p). Once the Blue touch paper is ignited these kind of stocks tend to have a mind of their own and just explode! Speculative punt.